Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes.

Bastard P. et al, (2022), The Journal of experimental medicine, 219

Sero-prevalence of 19 infectious pathogens and associated factors among middle-aged and elderly Chinese adults: a cross-sectional study.

Yao P. et al, (2022), BMJ open, 12

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

Närhi F. et al, (2022), The Lancet Digital Health, 4, e220 - e234

Vitamin D Deficiency and Its Association with Iron Deficiency in African Children

Mogire RM. et al, (2022), Nutrients, 14, 1372 - 1372

Divergent trajectories of antiviral memory after SARS-CoV-2 infection.

Tomic A. et al, (2022), Nature communications, 13

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Ahern DJ. et al, (2022), Cell, 185, 916 - 938.e58

Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial

Fisher BA. et al, (2022), The Lancet Respiratory Medicine, 10, 255 - 266

Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom's COVID-19 Public Health Response.

Otter AD. et al, (2022), Microbiology spectrum, 10

Memory cytotoxic SARS-CoV-2 spike protein-specific CD4+ T cells associate with viral control

Dong T. et al, (2022)

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abani O. et al, (2022), The Lancet, 399, 665 - 676

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15

Response to Letter to the Editor by Ish et al. entitled ‘COVID-19 vaccine equity—the need of the hour’

Maclean P. et al, (2022), QJM: An International Journal of Medicine

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abani O. et al, (2022), The Lancet, 399, 143 - 151

Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number

Keeling MJ. et al, (2022), Statistical Methods in Medical Research

Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Dejnirattisai W. et al, (2021)

Why do breakthrough COVID-19 infections occur in the vaccinated?

Maclean P. et al, (2021), QJM : monthly journal of the Association of Physicians

A haemagglutination test for rapid detection of antibodies to SARS-CoV-2

Townsend A. et al, (2021), Nature Communications, 12

An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

Peng Y. et al, (2021), Nature Immunology

Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England

Leclerc QJ. et al, (2021), BMC Health Services Research, 21

Mapping the human genetic architecture of COVID-19.

COVID-19 Host Genetics Initiative None., (2021), Nature, 600, 472 - 477

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?